placeholder newsslider


ARVO2020 cancelled because of Coronavirus (COVID-19)

ARVO has decided to cancel the Annual Meeting to have taken place May 1 – 7 in Baltimore, Md, USA

New Technologies for Outcome Measures in Uveal Melanoma

Basel Series of Special Interest Focus Groups (SIFG) - „New Technologies for Outcome Measures in Uveal Melanoma” In Collaboration with the European Ocular Oncology Group and the International Society of Ocular Oncology

Drive-through IOP screening clinic feasible during COVID-19

A drive-through intraocular pressure (IOP) screening clinic allows for continued management during the COVID-19 pandemic, according to a research letter published in JAMA Ophthalmology.

Core curriculum: learning to manage a shared microscopy facility

High-tech tools are increasingly being consolidated into specialized centres. Running these technological wonderlands takes a unique blend of skills.

Global public health services fail to meet targets to reduce avoidable sight loss

A new global study has found no significant reduction in the number of people with treatable sight loss since 2010. Published in The Lancet Global Health, it examined population-based surveys of eye disease worldwide from 1980 and found public health services across the world are failing to meet targets to reduce avoidable sight loss.

The best science images of 2020

2020 has been a year like no other. The COVID-19 pandemic pushed science to the forefront and dominated lives. But the year also produced fresh images unrelated to the virus.

RetinAI collaborates with Novartis to provide AI solutions for ophthalmology projects

RetinAI Medical AG announces a multi-year collaboration with Novartis Pharma AG under which RetinAI’s IT solutions and artificial intelligence tools shall be employed to support multiple projects in ophthalmology and digital health. Both companies have previously worked successfully on pilot projects in this disease area.

Glaucoma Research Foundation going global

In light of the ongoing COVID-19 pandemic, the Glaucoma Research Foundation will host a virtual Glaucoma 360 annual meeting in 2021.

ARVO 2021 going fully virtual

The Association for Research in Vision and Ophthalmology announced the switch to a virtual format this week for its annual meeting, originally scheduled for May 2-6 in San Francisco.

Heidelberg imaging platforms poised for future of ophthalmology

Ram Liebenthal, U.S. general manager for Heidelberg Engineering, discusses how the company continues to invest in the Spectralis platform in terms of hardware and software improvements.

AAO Appoints Emily Chew, MD, as Editor-in-Chief of Ophthalmology Science

The American Academy of Ophthalmology today announced the appointment of Emily Chew, MD, as editor in chief of Ophthalmology Science, the fourth and newest addition to the Academy’s Ophthalmology® family of journals. Dr. Chew is a highly respected medical retina specialist and editor, with extensive experience in the design and implementation of clinical trials.

American Academy of Ophthalmology Leads Global Initiative to Address Worldwide Myopia Epidemic

The number of Americans who are nearsighted has nearly doubled over the last 50 years to about 41.6 percent. This upward trend is evident in nearly every corner of the world, but nowhere near as dramatic as in East and Southeast Asia, where 80 to 90 percent of children and young adults are myopic.

Alcon showcases advanced IOL technology for presbyopia

Kristen Brotherson, vice president, US surgical marketing for Alcon, discusses some of the recent advances in cataract surgery-related technologies, including a new advanced lens for patients with presbyopia (AcrySof IQ Vivity IOL).

Major European research scheme gets €4-billion boost

Last-minute budget increase still leaves the upcoming Horizon Europe programme billions short of campaigners’ hopes.

US president-elect Joe Biden must quickly restore science to government

The election of Biden and Kamala Harris is a win for facts, research and empathy. Each of these must be deployed to fight the pandemic, combat misinformation, mitigate climate change and rebuild the United States’ global relationships.